News + Events
CAIRE Inc. Announces Acquisition of Spirosure Inc.
Establishes CAIRE Diagnostics Inc. business unit to broaden product portfolio ~ Ball Ground, GA (June 3, 2020) – CAIRE Inc., a leader in respiratory solutions for the global health care community, announced the acquisition of Spirosure, Inc....
Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Spirosure’s Fenom Pro® Asthma Monitor in Multiple Countries
https://www.prnewswire.com/news-releases/vyaire-medical-enters-exclusive-five-year-agreement-to-distribute-spirosures-fenom-pro-asthma-monitor-in-multiple-countries-300983457.html
Spirosure Receives FDA Clearance to Sell Its Point-of-Care Asthma Monitor, Fenom Pro™
PLEASANTON, Calif., Feb. 25, 2019 — Spirosure Inc. announced today that it has received FDA clearance of its patent-protected Fenom Pro Asthma Monitor for use by allergists, immunologists and pulmonologists to help patients manage asthma by...
Subscribe to Diagnostics News + Events
Related Posts
CAIRE Completes Acquisition of MGC Diagnostics Holdings, Inc.
Company Further Expands Clinical Healthcare Portfolio for Patients Facing Pulmonary Disease Ball...
CAIRE to Acquire MGC Diagnostics Holdings, Inc.
Portfolio Expands to Include Non-Invasive Cardiorespiratory Diagnostic Systems Ball Ground, GA,...